Compare IDYA & DAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IDYA | DAN |
|---|---|---|
| Founded | 2015 | 1904 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Auto Parts:O.E.M. |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.9B | 3.3B |
| IPO Year | 2019 | N/A |
| Metric | IDYA | DAN |
|---|---|---|
| Price | $32.39 | $32.10 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 14 | 5 |
| Target Price | ★ $49.67 | $31.40 |
| AVG Volume (30 Days) | 858.2K | ★ 1.8M |
| Earning Date | 02-13-2026 | 02-18-2026 |
| Dividend Yield | N/A | ★ 1.26% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.39 |
| Revenue | $214,834,000.00 | ★ $9,957,000,000.00 |
| Revenue This Year | $2,688.43 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $81.44 |
| Revenue Growth | ★ 5377.66 | 17.78 |
| 52 Week Low | $13.45 | $10.11 |
| 52 Week High | $39.28 | $31.81 |
| Indicator | IDYA | DAN |
|---|---|---|
| Relative Strength Index (RSI) | 41.60 | 77.03 |
| Support Level | $31.54 | $29.70 |
| Resistance Level | $34.66 | $31.01 |
| Average True Range (ATR) | 1.38 | 1.20 |
| MACD | -0.32 | 0.05 |
| Stochastic Oscillator | 16.84 | 93.86 |
IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its approach integrates small molecule drug discovery with extensive capabilities in identifying and validating translational biomarkers to develop targeted therapies for select patient populations that are likely to benefit from these targeted therapies. The company's clinical-stage product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275/GSK959 (Werner Helicase), IDE161 (PARG), and IDE705/GSK101 (Pol Theta Helicase). In addition, it also working on other development candidates and has multiple earlier-stage preclinical programs.
Dana Inc is engaged in the designing and manufacturing of efficient propulsion and energy-management solutions that power vehicles and machines in all mobility markets across the globe. The company has four operating segments: Light Vehicles, Power Technologies, Commercial Vehicle, and Off-Highway. The Light Vehicles segment generates the majority portion of revenue by providing products to support light vehicle OEMs. Its products are designed for light trucks, SUVs, CUVs, vans, and passenger cars.